Clinical Trial Update: A Pilot Study Evaluating the Immunologic Status of Patients With HER2+ Breast Cancer

View source ↗

Summary

This clinical trial update reports on a pilot study evaluating the immunologic status of patients with HER2-positive breast cancer. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Stanford University | Conditions: Breast Cancer | Status: COMPLETED